UNCONTROLLED HYPERTENSION
Clinical trials for UNCONTROLLED HYPERTENSION explained in plain language.
Never miss a new study
Get alerted when new UNCONTROLLED HYPERTENSION trials appear
Sign up with your email to follow new studies for UNCONTROLLED HYPERTENSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New blood pressure drug QLS1410 enters first human tests
Disease control Not yet recruitingThis early-stage trial tests the safety and tolerability of a new drug called QLS1410 in 78 healthy Chinese adults and people with mild high blood pressure. Researchers will give single and multiple doses to see how the body processes the drug and how food affects it. The goal is…
Matched conditions: UNCONTROLLED HYPERTENSION
Phase: PHASE1 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 17, 2026 06:52 UTC
-
New device could zap away high blood pressure without pills
Disease control Not yet recruitingThis study tests a device called the Netrod renal denervation system in 20 adults with high blood pressure who are not taking blood pressure medication. The device uses energy to calm nerves near the kidneys that can raise blood pressure. The goal is to see if it safely lowers bl…
Matched conditions: UNCONTROLLED HYPERTENSION
Phase: NA • Sponsor: Shanghai Golden Leaf MedTec Co. Ltd • Aim: Disease control
Last updated May 13, 2026 16:00 UTC
-
12 healthy volunteers to test if food changes drug absorption
Knowledge-focused Not yet recruitingThis early-stage study looks at how taking a new drug (QLS1410) with or without food changes its levels in the blood. It involves 12 healthy Chinese adults and is not intended to treat any condition. The results will help guide future dosing instructions for people with uncontrol…
Matched conditions: UNCONTROLLED HYPERTENSION
Phase: PHASE1 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Knowledge-focused
Last updated May 12, 2026 13:41 UTC